Vitamin K2 MK-7 (Menaquinone-7)

Vitamin K2 MK-7 (menaquinone-7) is the most bioactive form of vitamin K2 that activates matrix Gla protein and osteocalcin to regulate calcium metabolism. It directs calcium away from arteries and into bones, supporting both cardiovascular and skeletal health.

Origin & History

Vitamin K2 MK-7, or menaquinone-7, is a form of vitamin K2 found in fermented foods like natto. It is produced via bacterial fermentation processes.

Historical & Cultural Context

Vitamin K2 was discovered in the 1930s, with MK-7 later identified as a potent form found in traditional Japanese natto.

Health Benefits

- Supports bone health by directing calcium to bones and teeth, reducing the risk of osteoporosis by up to 25% according to studies. It enhances bone mineral density, crucial for aging populations. - Promotes cardiovascular health by preventing arterial calcification, which can decrease heart disease risk by 41%. This mechanism ensures calcium is utilized effectively. - Enhances dental health by improving the mineralization of teeth, reducing cavities by up to 50%. This is vital for maintaining oral hygiene. - Boosts immune function by modulating inflammatory responses, which can enhance overall immunity. This helps the body respond better to infections. - Supports brain health by reducing oxidative stress, potentially lowering the risk of neurodegenerative diseases. This is crucial for cognitive longevity. - Improves skin elasticity by promoting collagen synthesis, leading to a 20% reduction in wrinkles. This benefit is essential for maintaining youthful skin. - Aids in reducing the risk of cancer by regulating cell growth and apoptosis, which is critical for preventing abnormal cell proliferation.

How It Works

MK-7 serves as a cofactor for gamma-glutamyl carboxylase, which activates vitamin K-dependent proteins including osteocalcin and matrix Gla protein (MGP). Activated osteocalcin binds calcium to hydroxyapatite in bone matrix, while activated MGP prevents calcium deposition in arterial walls and soft tissues. This dual mechanism optimizes calcium utilization throughout the body.

Scientific Research

RCTs and observational studies support MK-7's role in bone and cardiovascular health. Emerging research suggests benefits for skin and metabolic health.

Clinical Summary

The Rotterdam Study (4,807 participants over 7 years) showed 57% reduction in severe aortic calcification with higher K2 intake. A 3-year randomized controlled trial of 244 postmenopausal women found MK-7 supplementation (180 mcg daily) improved bone mineral density and reduced bone loss markers. Multiple studies demonstrate MK-7's superior bioavailability compared to MK-4, with longer half-life enabling once-daily dosing. Evidence is strongest for bone and cardiovascular outcomes in older adults.

Nutritional Profile

- Fat-soluble vitamin. - Long-chain menaquinone form. - Essential for calcium regulation.

Preparation & Dosage

Typical dosage ranges from 90 to 200 mcg per day. Consult a healthcare provider before use.

Synergy & Pairings

Vitamin D3, Calcium, Magnesium

Safety & Interactions

MK-7 is generally well-tolerated with no reported serious adverse effects in clinical trials up to 360 mcg daily. It may enhance warfarin's anticoagulant effects, requiring INR monitoring in patients on vitamin K antagonists. Unlike warfarin interaction concerns, MK-7 doesn't appear to interfere with newer anticoagulants like rivaroxaban. Pregnancy and lactation safety data is limited, though vitamin K2 is naturally present in breast milk.